alexa 2,7- Phloroglucinol-6,6-bieckol Protects INS-1 Pancreatic β Cells Against High Glucose-induced Apoptosis
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

9th Annual European Pharma Congress
June 26-28, 2017 Madrid, Spain

Ji Sook Han, Hyun Ah Lee and Ji Hyeok Lee
Pusan National University, Republic of Korea
Lee Gil Ya Cancer and Diabetes Institute, Republic of Korea
Posters & Accepted Abstracts: Pharmaceut Reg Affairs
DOI: 10.4172/2167-7689-C1-025
Background: Impaired function and decreasing numbers of pancreatic β cells are key factors in development of type 2 diabetes. Aim: The aim of this study is to investigate whether 2,7"-phloroglucinol-6,6'-bieckol protects INS-1 pancreatic β cells against high glucose-induced glucotoxicity and apoptosis. Results: High-glucose (30 mM) treatment led to glucotoxicity and induced apoptosis in INS-1 pancreatic β cells. But treatment with 10~50 μM of 2,7"-phloroglucinol-6,6'-bieckol significantly alleviated the glucotoxicity and increased the cell viability. The treatment with 2,7"-phloroglucinol-6,6'-bieckol decreased dose dependently intracellular reactive oxygen species, lipid peroxidation, and nitric oxide levels increased by high glucose treatment. Furthermore, 2,7"-phloroglucinol-6,6'-bieckol significantly reduced pro-apoptotic Bax, caspase 9, and caspase 3 expressions, whereas it increased anti-apoptotic Bcl-2 and PARP expressions. When the type of cell death was identified using annexin V/propidium iodide staining, 2,7"-phloroglucinol-6,6'-bieckol significantly decreased the numbers of early apoptotic and late apoptotic cells induced by high glucose. Conclusion: These results suggest that 2,7"-phloroglucinol-6,6'-bieckol might be useful as a potential pharmaceutical agent to protect the pancreatic β cells against high glucose-induced apoptosis.

Ji Sook Han is a Professor and is doing research on developing a bioactive compound from natural plants, especially seaweeds, and investigating its effect for the prevention and treatment of obesity and type 2 diabetes. The active compound containing in seaweeds may be a good anti-diabetic source by improving insulin secretary defect or insulin resistance. It may also be a potential anti-obesity source owing to its inhibitory effect on adipogenesis. She evaluates the effect and mechanism of a bioactive compound isolated from natural plant through in vitro and in vivo study.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version